Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry.
- J. Beyer-Westendorf, Kati Förster, N. Weiss
- MedicineBlood
- 7 August 2014
The data indicate that, in real life, rates of rivaroxaban-related major bleeding may be lower and that the outcome may at least not be worse than that of major vitamin K antagonist bleeding, and probably better.
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.
- J. Beyer-Westendorf, S. Schellong, R. Bauersachs
- MedicineThe Lancet Haematology
- 1 March 2017
Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.
- J. Beyer-Westendorf, Franziska Ebertz, N. Weiss
- MedicineThrombosis and Haemostasis
- 2015
The effectiveness and safety of dabigatran for stroke prevention in atrial fibrillation (SPAF) demonstrated in RE-LY needs to be confirmed in daily care and data from an ongoing, prospective, non-interventional registry of more than 2,500 patients on novel oral anticoagulants in daily Care contribute to the confirmation.
Drug persistence with rivaroxaban therapy in atrial fibrillation patients—results from the Dresden non-interventional oral anticoagulation registry
- J. Beyer-Westendorf, Kati Förster, N. Weiss
- MedicineEuropace
- 18 February 2015
Overall persistence with rivaroxaban therapy is high, with a discontinuation rate of ∼15% in the first year of treatment and few additional discontinuations thereafter, using data from a prospective, non-interventional oral anticoagulation registry.
Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.
- R. Turan, İ. Bozdağ-Turan, H. Ince
- Medicine, BiologyCirculation Journal
- 25 February 2011
These results demonstrate for the first time that intracoronary transplantation of autologous freshly isolated BMCs by use of a point of care system is safe, and may lead to improvement of cardiac function in patients with AMI.
Improved Functional Activity of Bone Marrow Derived Circulating Progenitor Cells After Intra Coronary Freshly Isolated Bone Marrow Cells Transplantation in Patients with Ischemic Heart Disease
- R. Turan, I. Bozdag-T, H. Ince
- Medicine, BiologyStem Cell Reviews and Reports
- 29 December 2010
Intracoronary transplantation of autologous freshly isolated BMCs by use of point of care system may lead to improvement of BM-CPCs functional activity in peripheral blood, which might increase the regenerative potency in patients with IHD.
Enhanced mobilization of the bone marrow–derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction
- R. Turan, I. Bozdag-T, H. Ince
- Medicine, BiologyJournal of Cellular and Molecular Medicine
- 1 April 2012
Intracoronary transplantation of autologous freshly isolated BMCs by use of point of care system in patients with AMI may enhance and prolong the mobilization of CD34/45+ and CD133/ 45+ BM‐CPCs in PB and this might increase the regenerative potency after AMI.
Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.
- Judith Hecker, S. Marten, J. Beyer-Westendorf
- MedicineThrombosis and Haemostasis
- 5 March 2015
The effectiveness and safety of rivaroxaban for stroke prevention in atrial fibrillation (SPAF) demonstrated in ROCKET AF needs to be confirmed in daily care and data from an ongoing, prospective, non-interventional registry of more than 2700 patients on novel oral anticoagulants in daily Care contribute to the confirmation.
Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
- H. Kooistra, M. Gebel, K. Sahin, A. Lensing, K. Meijer
- MedicineThrombosis and Haemostasis
- 25 November 2015
Several independent predictors of low iTTR and instability > 28 days showed some similarities but did not fully overlap, and early VKA control was of additional value for prediction of both, but had to be interpreted in the context of VKA type.
...
...